192 related articles for article (PubMed ID: 28916499)
1. (Re-)programming of subtype specific cardiomyocytes.
Hausburg F; Jung JJ; Hoch M; Wolfien M; Yavari A; Rimmbach C; David R
Adv Drug Deliv Rev; 2017 Oct; 120():142-167. PubMed ID: 28916499
[TBL] [Abstract][Full Text] [Related]
2. Generation of human cardiomyocytes for cardiac regenerative therapies: differentiation and direct reprogramming.
Hodonsky C; Wu K; Mundada L; Si MS
Curr Pharm Des; 2014; 20(12):2012-22. PubMed ID: 23844731
[TBL] [Abstract][Full Text] [Related]
3. Specific Cell (Re-)Programming: Approaches and Perspectives.
Hausburg F; Jung JJ; David R
Adv Biochem Eng Biotechnol; 2018; 163():71-115. PubMed ID: 29071403
[TBL] [Abstract][Full Text] [Related]
4. Strategies for heart regeneration: approaches ranging from induced pluripotent stem cells to direct cardiac reprogramming.
Yamakawa H; Ieda M
Int Heart J; 2015; 56(1):1-5. PubMed ID: 25742939
[TBL] [Abstract][Full Text] [Related]
5. From pluripotency to distinct cardiomyocyte subtypes.
David R; Franz WM
Physiology (Bethesda); 2012 Jun; 27(3):119-29. PubMed ID: 22689787
[TBL] [Abstract][Full Text] [Related]
6. Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications.
Yoshida Y; Yamanaka S
Circ Res; 2017 Jun; 120(12):1958-1968. PubMed ID: 28596174
[TBL] [Abstract][Full Text] [Related]
7. Induced regeneration--the progress and promise of direct reprogramming for heart repair.
Addis RC; Epstein JA
Nat Med; 2013 Jul; 19(7):829-36. PubMed ID: 23836233
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Non-Coding RNAs in Exosomes and Functional Efficacy of Human Embryonic Stem Cell- versus Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Lee WH; Chen WY; Shao NY; Xiao D; Qin X; Baker N; Bae HR; Wei TT; Wang Y; Shukla P; Wu H; Kodo K; Ong SG; Wu JC
Stem Cells; 2017 Oct; 35(10):2138-2149. PubMed ID: 28710827
[TBL] [Abstract][Full Text] [Related]
9. Pluripotent reprogramming and lineage reprogramming: promises and challenges in cardiovascular regeneration.
He WJ; Hou Q; Han QW; Han WD; Fu XB
Tissue Eng Part B Rev; 2014 Aug; 20(4):304-13. PubMed ID: 24063625
[TBL] [Abstract][Full Text] [Related]
10. Translational potential of human embryonic and induced pluripotent stem cells for myocardial repair: insights from experimental models.
Kong CW; Akar FG; Li RA
Thromb Haemost; 2010 Jul; 104(1):30-8. PubMed ID: 20539906
[TBL] [Abstract][Full Text] [Related]
11. Programming and reprogramming a human heart cell.
Sahara M; Santoro F; Chien KR
EMBO J; 2015 Mar; 34(6):710-38. PubMed ID: 25712211
[TBL] [Abstract][Full Text] [Related]
12. Genetic and Epigenetic Regulation of Human Cardiac Reprogramming and Differentiation in Regenerative Medicine.
Burridge PW; Sharma A; Wu JC
Annu Rev Genet; 2015; 49():461-84. PubMed ID: 26631515
[TBL] [Abstract][Full Text] [Related]
13. Direct Reprogramming, Epigenetics, and Cardiac Regeneration.
Kurotsu S; Suzuki T; Ieda M
J Card Fail; 2017 Jul; 23(7):552-557. PubMed ID: 28529134
[TBL] [Abstract][Full Text] [Related]
14. Regenerative Medicine/Cardiac Cell Therapy: Pluripotent Stem Cells.
Duran AG; Reidell O; Stachelscheid H; Klose K; Gossen M; Falk V; Röll W; Stamm C
Thorac Cardiovasc Surg; 2018 Jan; 66(1):53-62. PubMed ID: 29216651
[TBL] [Abstract][Full Text] [Related]
15. Induced pluripotent stem cell-derived cardiomyocytes for drug development and toxicity testing.
Sinnecker D; Laugwitz KL; Moretti A
Pharmacol Ther; 2014 Aug; 143(2):246-52. PubMed ID: 24657289
[TBL] [Abstract][Full Text] [Related]
16. Human-Induced Pluripotent Stem Cell-Based Differentiation of Cardiomyocyte Subtypes for Drug Discovery and Cell Therapy.
Pan Z; Liang P
Handb Exp Pharmacol; 2023; 281():209-233. PubMed ID: 37421443
[TBL] [Abstract][Full Text] [Related]
17. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
Talkhabi M; Aghdami N; Baharvand H
Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
[TBL] [Abstract][Full Text] [Related]
18. Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications.
Sadahiro T; Yamanaka S; Ieda M
Circ Res; 2015 Apr; 116(8):1378-91. PubMed ID: 25858064
[TBL] [Abstract][Full Text] [Related]
19. Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand?
Ebert AD; Diecke S; Chen IY; Wu JC
EMBO Mol Med; 2015 Sep; 7(9):1090-103. PubMed ID: 26183451
[TBL] [Abstract][Full Text] [Related]
20. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
